
### [MONDO:0016328](http://purl.obolibrary.org/obo/MONDO_0016328)
**Label:** fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy

**Subclasses:** [MONDO:0009282](http://purl.obolibrary.org/obo/MONDO_0009282) (multiple acyl-CoA dehydrogenase deficiency), [MONDO:0012173](http://purl.obolibrary.org/obo/MONDO_0012173) (long chain 3-hydroxyacyl-CoA dehydrogenase deficiency), [MONDO:0012172](http://purl.obolibrary.org/obo/MONDO_0012172) (mitochondrial trifunctional protein deficiency), [MONDO:0008918](http://purl.obolibrary.org/obo/MONDO_0008918) (carnitine-acylcarnitine translocase deficiency), [MONDO:0018332](http://purl.obolibrary.org/obo/MONDO_0018332) (multiple acyl-CoA dehydrogenase deficiency, severe neonatal type), [MONDO:0018333](http://purl.obolibrary.org/obo/MONDO_0018333) (multiple acyl-CoA dehydrogenase deficiency, mild type), [MONDO:0020531](http://purl.obolibrary.org/obo/MONDO_0020531) (long chain acyl-CoA dehydrogenase deficiency), [MONDO:0008723](http://purl.obolibrary.org/obo/MONDO_0008723) (very long chain acyl-CoA dehydrogenase deficiency), [MONDO:0012624](http://purl.obolibrary.org/obo/MONDO_0012624) (acyl-CoA dehydrogenase 9 deficiency), 

**Corr. equiv. classes:** [Orphanet:26793](http://www.orpha.net/ORDO/Orphanet_26793), [Orphanet:5](http://www.orpha.net/ORDO/Orphanet_5), [Orphanet:394532](http://www.orpha.net/ORDO/Orphanet_394532), [OMIM:201475](http://purl.obolibrary.org/obo/OMIM_201475), [Orphanet:26791](http://www.orpha.net/ORDO/Orphanet_26791), [OMIM:212138](http://purl.obolibrary.org/obo/OMIM_212138), [OMIM:611126](http://purl.obolibrary.org/obo/OMIM_611126), [Orphanet:746](http://www.orpha.net/ORDO/Orphanet_746), [OMIM:609016](http://purl.obolibrary.org/obo/OMIM_609016), [Orphanet:99900](http://www.orpha.net/ORDO/Orphanet_99900), [Orphanet:99901](http://www.orpha.net/ORDO/Orphanet_99901), [OMIM:609015](http://purl.obolibrary.org/obo/OMIM_609015), [Orphanet:394529](http://www.orpha.net/ORDO/Orphanet_394529), [Orphanet:159](http://www.orpha.net/ORDO/Orphanet_159), [OMIM:231680](http://purl.obolibrary.org/obo/OMIM_231680), 

**Class expressions from DL-Learner:**

- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0001943](http://purl.obolibrary.org/obo/HP_0001943) (Hypoglycemia) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0001392](http://purl.obolibrary.org/obo/HP_0001392) (Abnormality of the liver) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 63.33%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0003215](http://purl.obolibrary.org/obo/HP_0003215) (Dicarboxylic aciduria) and [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) 63.33%


